Steve Harris

Small Pharma Ltd. operates as a pharmaceutical company that develops a rapid-acting antidepressant to treat patients with depression. The company was founded by Peter Rands in 2015 and is headquartered in London, the United Kingdom.

Ocelus Ltd. is an early stage specialty pharmaceutical company, developing and commercializing the micro implant drug delivery system conceived by Dr Andrew Kirby. Founded in late 2007, Ocelus Ltd is based in South Wales, UK, Ocelus Ltd has been awarded two Welsh Assembly Government innovation grants, and has attracted venture capital funding from Finance Wales. Ocelus' technology was conceived as the answer for delivery of high molecular weight drugs through the skin. Micro needles and other poration technologies are low pain due to the size of the holes made, but suffer from problems in reproducibility of dose, and can only deliver relatively small quantities of drug, whereas large scale single implants are effective and incorporate controlled release of drug over time, but can be painful in use. Ocelus' technology was designed to combine the best of both systems, with small particles being simultaneously injected into the skin at hundreds of sites per square centimeter. These remain in the skin and dissolve rapidly or slowly to release drug.

Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom.

Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines.

The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010.